Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Rare Disease Life Foundation (RDL Foundation) is a non-profit organization dedicated to improving the lives of patients suffering from rare diseases, particularly Lysosomal Storage Disorders (LSDs). Based in India, the foundation focuses on patient advocacy, awareness, and facilitating access to life-saving treatments and clinical trials. RDL Foundation works closely with healthcare providers, government bodies, and pharmaceutical companies to bridge the gap in rare disease management and policy. Their initiatives include patient support groups, diagnostic assistance, and lobbying for better healthcare infrastructure for rare disease patients.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on RDL Foundation.